Copenhagen Life Science Summit October 8-9 2025
| Dokumendiregister | Majandus- ja Kommunikatsiooniministeerium |
| Viit | 6-4/2273-1 |
| Registreeritud | 12.06.2025 |
| Sünkroonitud | 13.06.2025 |
| Liik | Sissetulev kiri |
| Funktsioon | 6 Rahvusvahelise koostöö korraldamine |
| Sari | 6-4 Tervitus- ja tutvustuskirjad, kutsed üritustel osalemiseks |
| Toimik | 6-4/2025 |
| Juurdepääsupiirang | Avalik |
| Juurdepääsupiirang | |
| Adressaat | Healtcare Denmark |
| Saabumis/saatmisviis | Healtcare Denmark |
| Vastutaja | Silver Tammik (Majandus- ja Kommunikatsiooniministeerium, Kantsleri valdkond, Strateegia ja teenuste juhtimise valdkond, EL ja rahvusvahelise koostöö osakond) |
| Originaal | Ava uues aknas |
Failid
1
PRELIMINARY PROGRAMME
Copenhagen Life Science Summit
Life Science: A Catalyst for European Compe77veness October 8-9 2025
The life science sector is one of Europe’s key strengths and a cornerstone of our socie7es, delivering be;er health for ci7zens, economic produc7vity and growth, as well as medicine security. Yet, the EU faces two pressing challenges that threaten its long-term ability to improve pa7ent care: European compe77veness is waning as the private sector struggles to keep pace with global rivals in the race for innova7on and investment. Meanwhile, wide gaps persist across member states, both in the sector’s economic contribu7on to society and in the access to innova7ve medicines. Enhancing European compe77veness and spreading its gains across the Union are essen7al to building stronger health systems for the benefit of pa7ents and prac77oners alike. Inves7ng in health enhances economic produc7vity, reduces healthcare costs, and fosters social equity by ensuring access to care and improving overall well-being. It also strengthens societal resilience, drives innova7on through public-private collabora7ons, and supports long-term sustainability in health systems. On October 8, Healthcare Denmark will host a recep7on at the Copenhagen City Hall. On October 9, the Copenhagen Life Science Summit - Life Science: A Catalyst for European Compe99veness will explore how Europe can reclaim its leadership in life sciences while aligning public and private goals to ensure that the benefits of compe77veness are widely shared. The conference will focus on how forthcoming ini7a7ves under the EU’s Compe99veness Compass can drive progress across five horizontal enablers: lowering barriers to the single market; expanding access to investment; fostering skills, quality jobs and social fairness; simplifying regula7on; and improving policy coordina7on across member states. Discussions will center on how to unlock Europe’s poten7al by making sure that strategic investment in health and stronger public-private partnerships can enhance economic produc7vity, reduce healthcare costs, and build social resilience and equity by ensuring access to care and improving overall well-being.
2
Preliminary Programme Wednesday October 8 Venue: Copenhagen City Hall, Raadhuspladsen 1, Copenhagen
Time Content Speakers Recep%on
17.30 Arrival,
registra:on and networking
18.00 Welcome
Lars Weiss, Lord Mayor, Copenhagen
18.10 Opening remarks
Sophie Løhde, Minister for the Interior and Health, Denmark
18.30 Networking dinner
20.00 End of recep:on
Thursday October 9 Venue: Mærsk Tower, Copenhagen University, Blegdamsvej 3B, Copenhagen N
Time Content Speakers Conference 08.00 Arrival,
registra:on and networking
09.00 Welcome and opening remarks
David Dreyer Lassen, Rector, University of Copenhagen & Lykke Friis, Director, Think Tank EUROPA
09.15 Opening Keynote Unlocking Europe’s Poten3al: A Life Sciences Strategy for Prosperity and Health Stéphane Séjourné, Execu:ve Vice-President for Prosperity and Industrial Strategy, European Commission (TBC)
3
The opening keynote will present the Commission’s vision for strengthening Europe’s life sciences sector, detailing key policy ini<a<ves under the Strategy for Life Sciences and the Compe<<veness Compass.
09.35 Keynote Losing Ground? Challenges for Europe’s Life Sciences Sector in the Global Race for Innova3on
• Elizabeth Kuiper, Associate Director and Head of the Social Europe & Well-Being Programme, European Policy Centre
The keynote will assess the core drivers of Europe’s compe<<veness in life sciences and iden<fy future policy challenges for the EU.
09.55 Panel Debate Back in the Lead: How to Design a European Industrial Policy for Public Health and Innova3on Moderated by: Lykke Friis, Director, Think Tank EUROPA
• Ekaterina Zaharieva, Commissioner for Startups, Research, and Innova:on, European Commission (TBC)
• Stefan Oelrich, President, European Federa:on of Pharmaceu:cal Industries and Associa:on (TBC)
• Mónica García Gómez, Minister of Health, Spain (TBC) • CEO, Novo Nordisk A/S (TBC) • Dolors Montserrat, MEP; Member of Commi_ee on the
Environment, Climate and Food Safety (ENVI), European Parliament (TBC)
The panel will debate the priori<es for EU industrial policy by exploring the risks and poten<al of tools such as public investment, policy reform, and joint procurement to drive innova<on in life sciences while advancing European public health objec<ves.
10.40 Coffee Break
11.10 Fireside chat Aligning Public Goals with Corporate Growth: Lessons from the Nordic Experience Moderated by: Lykke Friis, Director, Think Tank EUROPA
• Lars Rasmussen, Chair of the Board for Coloplast and WS Audiology; Chair of the Danish Life Science Council
4
This session will present the lessons learned from the Nordic approach to public-private partnerships and explore how these strategies could be scaled at the European level.
11.25 Panel Debate Public-Private Partnerships: A Catalyst for European Compe33veness and Health? Moderated by: Lykke Friis, Director, Think Tank EUROPA
• Jennifer Carroll MacNeill, Minister for Health, Ireland (TBC) • Kers%n Jorna, Director-General for DG Internal Market, Industry,
Entrepreneurship and SMEs (DG GROW), European Commission (TBC)
• Charl Van Zyl, CEO, H. Lundbeck • S%ne Bosse, MEP, Vice-Chair on the Commi_ee on Public Health
(SANT), European Parliament The panel will examine the role of public-private partnerships in fostering life sciences innova<on and strengthening healthcare. Speakers will discuss how Europe can build more effec<ve na<onal and cross-border collabora<ons between the public and private sectors.
12.10 Networking Lunch
13.10 Keynote Why life science must be at the heart of Europe’s industrial strategy to drive innova3on, economic resilience, and public health
• Morten Bødskov, Minister for Industry, Business and Financial Affairs, Denmark
13.30 Panel Debate Unlocking the Societal Value of Innova3on: Shaping the Future of
Resilient, Sustainable and Innova3ve Healthcare in Europe Moderated by: DiOe Brasso Sørensen, Deputy Director, Think Tank EUROPA
• Sandra Gallina, Director-General for DG for Health and Food Safety (DG SANTE), European Commission
• Søren Nedergaard, CPO - Porcolio, People & Partnerships, Novo Nordisk Founda:on
• Teresa Graham, CEO, Roche Pharmaceu:cal • Marco Greco, President, European Pa:ents Forum (TBC)
5
The conversa<on will assess how strategic investments in life sciences can strengthen healthcare systems across Europe through economic growth and improved pa<ent outcomes.
14.15 Keynote Aligning Public Goals with Corporate Growth: Lessons from Europe
• Marc Ferracci, Minister for Industry and Energy, France (TBC)
14.30 Panel debate How to Boost Private Investment in Start-ups and Scale-ups: The Role of Regula3on and Capital Market Reform Moderated by: DiOe Brasso Sørensen, Deputy Director, ThinkTank EUROPA
• Gelsomina VigloR, Vice President, European Investment Bank (TBC)
• Jens Nielsen, CEO, BioInnova:on Ins:tute Founda:on, Copenhagen
• Kim Jørgensen (To be announced) • Rafaele Tordjman, Founder and CEO, Jeito Capital (TBC) • Pascal Canfin, MEP, Member of the Commi_ee on the
Environment, Climate and Food (ENVI); and the Commi_ee of Public Health (SANT), European Parliament (TBC)
This session will debate how the EU can bridge the private investment gap in life science research and innova<on – in par<cular what regulatory reforms are needed to unlock private funding and how the EU can steer capital markets towards socially beneficial investments.
15.15 Coffee Break
15.45 Panel Debate Spreading the Gains of Compe33veness: Enhancing Access to Innova3ve Healthcare Across the EU Moderated by: DiOe Brasso Sørensen, Deputy Director, ThinkTank EUROPA
• Anca Toma, Execu:ve Director, European Pa:ents Forum (TBC) • Vlas%mil Válek, Deputy Prime Minister and Minister of Health,
Czech Republic (TBC) • Benjamin RocheOe, Vice President, Global Regulatory Affairs,
Coloplast • Audrey Duval, Execu:ve Vice President of Corporate Affairs, Sanofi
(TBC) • Radan Kanev, MEP, Member of the Commi_ee on the
Environment, Climate and Food (ENVI), European Parliament (TBC)
6
The panel will discuss how the EU’s industrial strategy should be accompanied by measures to improve equitable access to innova<ve treatments and ensure that investments in new life sciences hubs deliver benefits across all member states, for example through regulatory reform, financing condi<onali<es, stronger coordina<on, or joint procurement.
16.30 Closing Remarks
Moving Forward: Next Steps for Europe Lars Løkke Rasmussen, Minister for Foreign Affairs, Denmark (TBC) The closing remarks will reflect on key takeaways from the conference and highlight ac<onable next steps for policymakers to reinforce Europe’s leadership in life sciences.
16.45 End of conference
16.45 Closing Recep:on
18.00 End of Closing Recep:on
Tähelepanu! Tegemist on välisvõrgust saabunud kirjaga. |
Dear Minister for Economy and Industry of Estonia, Erkki Keldo,
On behalf of Denmark’s Presidency of the Council of the European Union, it is a great pleasure for Healthcare Denmark and our partners to send a save-the-date invitation for Life Science: A Catalyst for European Competitiveness, a two-day conference which is part of Copenhagen Life Science Summit 2025, an official conference during Denmark’s Presidency of the Council of the European Union. The conference takes place on October 8-9 2025 in Copenhagen, Denmark.
Please find attached your save-the-date invitation and a preliminary programme. An official invitation will follow.
Should you be unable to attend, we kindly invite you to delegate your participation to your Deputy Secretary or another high-level representative from your ministry. Please inform us accordingly if your invitation is forwarded.
We are pleased to inform, that a number of prominent speakers and guests have confirmed their participation, and we hope for your participation as well.
More information is available online here: http://www.copenhagenlifesciencesummit.dk/
Please feel free to contact us if you have any questions or require further information.
Kind regards,
Inga
|
|
|
|
|
|
Inga Bohn Senior Advisor
|
+45 31 42 83 09
|
|
|
|
|
|
||
|
DK Odense M, 5230 | Forskerparken 10Y DK Copenhagen N, 2200 | Ole Maaløes Vej 3 |
|
||
1
PRELIMINARY PROGRAMME
Copenhagen Life Science Summit
Life Science: A Catalyst for European Compe77veness October 8-9 2025
The life science sector is one of Europe’s key strengths and a cornerstone of our socie7es, delivering be;er health for ci7zens, economic produc7vity and growth, as well as medicine security. Yet, the EU faces two pressing challenges that threaten its long-term ability to improve pa7ent care: European compe77veness is waning as the private sector struggles to keep pace with global rivals in the race for innova7on and investment. Meanwhile, wide gaps persist across member states, both in the sector’s economic contribu7on to society and in the access to innova7ve medicines. Enhancing European compe77veness and spreading its gains across the Union are essen7al to building stronger health systems for the benefit of pa7ents and prac77oners alike. Inves7ng in health enhances economic produc7vity, reduces healthcare costs, and fosters social equity by ensuring access to care and improving overall well-being. It also strengthens societal resilience, drives innova7on through public-private collabora7ons, and supports long-term sustainability in health systems. On October 8, Healthcare Denmark will host a recep7on at the Copenhagen City Hall. On October 9, the Copenhagen Life Science Summit - Life Science: A Catalyst for European Compe99veness will explore how Europe can reclaim its leadership in life sciences while aligning public and private goals to ensure that the benefits of compe77veness are widely shared. The conference will focus on how forthcoming ini7a7ves under the EU’s Compe99veness Compass can drive progress across five horizontal enablers: lowering barriers to the single market; expanding access to investment; fostering skills, quality jobs and social fairness; simplifying regula7on; and improving policy coordina7on across member states. Discussions will center on how to unlock Europe’s poten7al by making sure that strategic investment in health and stronger public-private partnerships can enhance economic produc7vity, reduce healthcare costs, and build social resilience and equity by ensuring access to care and improving overall well-being.
2
Preliminary Programme Wednesday October 8 Venue: Copenhagen City Hall, Raadhuspladsen 1, Copenhagen
Time Content Speakers Recep%on
17.30 Arrival,
registra:on and networking
18.00 Welcome
Lars Weiss, Lord Mayor, Copenhagen
18.10 Opening remarks
Sophie Løhde, Minister for the Interior and Health, Denmark
18.30 Networking dinner
20.00 End of recep:on
Thursday October 9 Venue: Mærsk Tower, Copenhagen University, Blegdamsvej 3B, Copenhagen N
Time Content Speakers Conference 08.00 Arrival,
registra:on and networking
09.00 Welcome and opening remarks
David Dreyer Lassen, Rector, University of Copenhagen & Lykke Friis, Director, Think Tank EUROPA
09.15 Opening Keynote Unlocking Europe’s Poten3al: A Life Sciences Strategy for Prosperity and Health Stéphane Séjourné, Execu:ve Vice-President for Prosperity and Industrial Strategy, European Commission (TBC)
3
The opening keynote will present the Commission’s vision for strengthening Europe’s life sciences sector, detailing key policy ini<a<ves under the Strategy for Life Sciences and the Compe<<veness Compass.
09.35 Keynote Losing Ground? Challenges for Europe’s Life Sciences Sector in the Global Race for Innova3on
• Elizabeth Kuiper, Associate Director and Head of the Social Europe & Well-Being Programme, European Policy Centre
The keynote will assess the core drivers of Europe’s compe<<veness in life sciences and iden<fy future policy challenges for the EU.
09.55 Panel Debate Back in the Lead: How to Design a European Industrial Policy for Public Health and Innova3on Moderated by: Lykke Friis, Director, Think Tank EUROPA
• Ekaterina Zaharieva, Commissioner for Startups, Research, and Innova:on, European Commission (TBC)
• Stefan Oelrich, President, European Federa:on of Pharmaceu:cal Industries and Associa:on (TBC)
• Mónica García Gómez, Minister of Health, Spain (TBC) • CEO, Novo Nordisk A/S (TBC) • Dolors Montserrat, MEP; Member of Commi_ee on the
Environment, Climate and Food Safety (ENVI), European Parliament (TBC)
The panel will debate the priori<es for EU industrial policy by exploring the risks and poten<al of tools such as public investment, policy reform, and joint procurement to drive innova<on in life sciences while advancing European public health objec<ves.
10.40 Coffee Break
11.10 Fireside chat Aligning Public Goals with Corporate Growth: Lessons from the Nordic Experience Moderated by: Lykke Friis, Director, Think Tank EUROPA
• Lars Rasmussen, Chair of the Board for Coloplast and WS Audiology; Chair of the Danish Life Science Council
4
This session will present the lessons learned from the Nordic approach to public-private partnerships and explore how these strategies could be scaled at the European level.
11.25 Panel Debate Public-Private Partnerships: A Catalyst for European Compe33veness and Health? Moderated by: Lykke Friis, Director, Think Tank EUROPA
• Jennifer Carroll MacNeill, Minister for Health, Ireland (TBC) • Kers%n Jorna, Director-General for DG Internal Market, Industry,
Entrepreneurship and SMEs (DG GROW), European Commission (TBC)
• Charl Van Zyl, CEO, H. Lundbeck • S%ne Bosse, MEP, Vice-Chair on the Commi_ee on Public Health
(SANT), European Parliament The panel will examine the role of public-private partnerships in fostering life sciences innova<on and strengthening healthcare. Speakers will discuss how Europe can build more effec<ve na<onal and cross-border collabora<ons between the public and private sectors.
12.10 Networking Lunch
13.10 Keynote Why life science must be at the heart of Europe’s industrial strategy to drive innova3on, economic resilience, and public health
• Morten Bødskov, Minister for Industry, Business and Financial Affairs, Denmark
13.30 Panel Debate Unlocking the Societal Value of Innova3on: Shaping the Future of
Resilient, Sustainable and Innova3ve Healthcare in Europe Moderated by: DiOe Brasso Sørensen, Deputy Director, Think Tank EUROPA
• Sandra Gallina, Director-General for DG for Health and Food Safety (DG SANTE), European Commission
• Søren Nedergaard, CPO - Porcolio, People & Partnerships, Novo Nordisk Founda:on
• Teresa Graham, CEO, Roche Pharmaceu:cal • Marco Greco, President, European Pa:ents Forum (TBC)
5
The conversa<on will assess how strategic investments in life sciences can strengthen healthcare systems across Europe through economic growth and improved pa<ent outcomes.
14.15 Keynote Aligning Public Goals with Corporate Growth: Lessons from Europe
• Marc Ferracci, Minister for Industry and Energy, France (TBC)
14.30 Panel debate How to Boost Private Investment in Start-ups and Scale-ups: The Role of Regula3on and Capital Market Reform Moderated by: DiOe Brasso Sørensen, Deputy Director, ThinkTank EUROPA
• Gelsomina VigloR, Vice President, European Investment Bank (TBC)
• Jens Nielsen, CEO, BioInnova:on Ins:tute Founda:on, Copenhagen
• Kim Jørgensen (To be announced) • Rafaele Tordjman, Founder and CEO, Jeito Capital (TBC) • Pascal Canfin, MEP, Member of the Commi_ee on the
Environment, Climate and Food (ENVI); and the Commi_ee of Public Health (SANT), European Parliament (TBC)
This session will debate how the EU can bridge the private investment gap in life science research and innova<on – in par<cular what regulatory reforms are needed to unlock private funding and how the EU can steer capital markets towards socially beneficial investments.
15.15 Coffee Break
15.45 Panel Debate Spreading the Gains of Compe33veness: Enhancing Access to Innova3ve Healthcare Across the EU Moderated by: DiOe Brasso Sørensen, Deputy Director, ThinkTank EUROPA
• Anca Toma, Execu:ve Director, European Pa:ents Forum (TBC) • Vlas%mil Válek, Deputy Prime Minister and Minister of Health,
Czech Republic (TBC) • Benjamin RocheOe, Vice President, Global Regulatory Affairs,
Coloplast • Audrey Duval, Execu:ve Vice President of Corporate Affairs, Sanofi
(TBC) • Radan Kanev, MEP, Member of the Commi_ee on the
Environment, Climate and Food (ENVI), European Parliament (TBC)
6
The panel will discuss how the EU’s industrial strategy should be accompanied by measures to improve equitable access to innova<ve treatments and ensure that investments in new life sciences hubs deliver benefits across all member states, for example through regulatory reform, financing condi<onali<es, stronger coordina<on, or joint procurement.
16.30 Closing Remarks
Moving Forward: Next Steps for Europe Lars Løkke Rasmussen, Minister for Foreign Affairs, Denmark (TBC) The closing remarks will reflect on key takeaways from the conference and highlight ac<onable next steps for policymakers to reinforce Europe’s leadership in life sciences.
16.45 End of conference
16.45 Closing Recep:on
18.00 End of Closing Recep:on
SAVE THE DATE:
COPENHAGEN LIFE SCIENCE SUMMIT Life Science: A Catalyst for European Competitiveness October 8-9 2025 | Copenhagen, Denmark
Join us for Life Science: A Catalyst for European Competitiveness, a part of Copenhagen Life Science Summit, an official conference during Denmark’s Presidency of the Council of the European Union in the second half of 2025. The conference is hosted by Healthcare Denmark, taking place in Copenhagen on October 8-9 2025.
The high-level conference will bring together decision-makers, public health organisations, industry, patient organisations, and academia from across EU27+, creating an international forum for the European life Science ecosystem to meet, exchange insights, and engage in discussions on the European Strategy for Life Sciences. The conference will explore the state of the current EU health and life science ecosystem, highlighting the need for a strong, integrated European ecosystem, with discussions on how to unlock Europe’s potential by making sure that strategic investment in health and stronger public-private partnerships can enhance economic productivity, reduce healthcare costs, and build social resilience and equity.
Together, we will explore how Europe can advance its position as a leading life science region – ensuring our competitiveness and contributing to more resilient, innovative health systems that benefit patients across Europe.
The two-day programme includes: • On October 8, a standing dinner reception at Copenhagen City Hall. • On October 9, the conference: Life Science: A Catalyst for European
Competitiveness at Maersk Tower, Copenhagen University.
Please mark your calendars now! In July 2025, when Denmark will hold the Presidency of the Council of the European Union, official invitations and registration details will be shared.
For further information and to view the preliminary program for Life Science: A Catalyst for European Competitiveness, kindly visit the official webpage for Copenhagen Life Science Summit here: http://www.copenhagenlifesciencesummit.dk/
Copenhagen Life Science Summit - co-hosted by Rigshospitalet and Healthcare Denmark - is financially supported by the European Commission; the Danish Ministry for Industry, Business and Financial Affairs; the Danish Ministry for Higher Education and Science; and Novo Nordisk Foundation.
SAVE THE DATE:
COPENHAGEN LIFE SCIENCE SUMMIT Life Science: A Catalyst for European Competitiveness October 8-9 2025 | Copenhagen, Denmark
Join us for Life Science: A Catalyst for European Competitiveness, a part of Copenhagen Life Science Summit, an official conference during Denmark’s Presidency of the Council of the European Union in the second half of 2025. The conference is hosted by Healthcare Denmark, taking place in Copenhagen on October 8-9 2025.
The high-level conference will bring together decision-makers, public health organisations, industry, patient organisations, and academia from across EU27+, creating an international forum for the European life Science ecosystem to meet, exchange insights, and engage in discussions on the European Strategy for Life Sciences. The conference will explore the state of the current EU health and life science ecosystem, highlighting the need for a strong, integrated European ecosystem, with discussions on how to unlock Europe’s potential by making sure that strategic investment in health and stronger public-private partnerships can enhance economic productivity, reduce healthcare costs, and build social resilience and equity.
Together, we will explore how Europe can advance its position as a leading life science region – ensuring our competitiveness and contributing to more resilient, innovative health systems that benefit patients across Europe.
The two-day programme includes: • On October 8, a standing dinner reception at Copenhagen City Hall. • On October 9, the conference: Life Science: A Catalyst for European
Competitiveness at Maersk Tower, Copenhagen University.
Please mark your calendars now! In July 2025, when Denmark will hold the Presidency of the Council of the European Union, official invitations and registration details will be shared.
For further information and to view the preliminary program for Life Science: A Catalyst for European Competitiveness, kindly visit the official webpage for Copenhagen Life Science Summit here: http://www.copenhagenlifesciencesummit.dk/
Copenhagen Life Science Summit - co-hosted by Rigshospitalet and Healthcare Denmark - is financially supported by the European Commission; the Danish Ministry for Industry, Business and Financial Affairs; the Danish Ministry for Higher Education and Science; and Novo Nordisk Foundation.